{"brief_title": "Combivent\u00ae CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma", "brief_summary": "The purpose of this study is to demonstrate the superior bronchodilator efficacy of inhaled Combivent\u00ae CFC MDI vs. Albuterol HFA MDI in moderate to severe asthma patients.", "condition": ["Asthma"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Combivent\u00ae CFC MDI", "Albuterol HFA MDI"], "criteria": "Inclusion Criteria: - Patient greater than or equal to 18 years of age, - non-smokers, - diagnosed with asthma, with an FEV1 less than or equal to 70 percent of predicted normal, - stable use of Beta agonist - daily use of inhaled steroids for one year Exclusion Criteria: - Patients with other significant diseases other than asthma, requiring oxygen, - intubated within 5 years, - asthma exacerbation within 6 weeks of trial, - use of unstable doses (greater than 10 mg/day of prednisone or equivalent) of steroids, - participating in another interventional trial", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Asthma", "Albuterol"], "id": "NCT00096616"}